AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)

Total Valuation

TPEX:7754 has a market cap or net worth of TWD 4.32 billion. The enterprise value is 3.87 billion.

Market Cap	4.32B
Enterprise Value	3.87B

Important Dates

The next estimated earnings date is Monday, September 22, 2025.

Earnings Date	Sep 22, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:7754 has 93.88 million shares outstanding. The number of shares has increased by 3.55% in one year.

Current Share Class	93.88M
Shares Outstanding	93.88M
Shares Change (YoY)	+3.55%
Shares Change (QoQ)	+1.61%
Owned by Insiders (%)	1.83%
Owned by Institutions (%)	12.48%
Float	57.84M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	181.25
PB Ratio	8.47
P/TBV Ratio	10.14
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-12.20
EV / Sales	162.25
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-13.16

Financial Position

The company has a current ratio of 4.99, with a Debt / Equity ratio of 0.10.

Current Ratio	4.99
Quick Ratio	4.66
Debt / Equity	0.10
Debt / EBITDA	n/a
Debt / FCF	-0.18
Interest Coverage	-201.18

Financial Efficiency

Return on equity (ROE) is -48.06% and return on invested capital (ROIC) is -29.73%.

Return on Equity (ROE)	-48.06%
Return on Assets (ROA)	-22.26%
Return on Invested Capital (ROIC)	-29.73%
Return on Capital Employed (ROCE)	-50.40%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.02
Inventory Turnover	0.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +32.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+32.04%
50-Day Moving Average	35.88
200-Day Moving Average	29.35
Relative Strength Index (RSI)	71.48
Average Volume (20 Days)	500,239

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:7754 had revenue of TWD 23.85 million and -317.13 million in losses. Loss per share was -3.38.

Revenue	23.85M
Gross Profit	468,000
Operating Income	-340.19M
Pretax Income	-317.13M
Net Income	-317.13M
EBITDA	-302.35M
EBIT	-340.19M
Loss Per Share	-3.38

Balance Sheet

The company has 505.55 million in cash and 52.37 million in debt, giving a net cash position of 453.18 million or 4.83 per share.

Cash & Cash Equivalents	505.55M
Total Debt	52.37M
Net Cash	453.18M
Net Cash Per Share	4.83
Equity (Book Value)	510.25M
Book Value Per Share	5.45
Working Capital	434.18M

Cash Flow

In the last 12 months, operating cash flow was -291.89 million and capital expenditures -2.23 million, giving a free cash flow of -294.12 million.

Operating Cash Flow	-291.89M
Capital Expenditures	-2.23M
Free Cash Flow	-294.12M
FCF Per Share	-3.13

Margins

Gross Margin	1.96%
Operating Margin	-1,426.25%
Pretax Margin	-1,329.58%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:7754 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.55%
Shareholder Yield	n/a
Earnings Yield	-7.34%
FCF Yield	-6.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2